Caris Life Sciences Announces $100M Share Repurchase Program

Caris Life Sciences (NASDAQ:CAI) announced a share repurchase program of up to $100 million, aiming to optimize its capital structure. The company plans to use existing cash reserves and will execute the buybacks through various methods including open market purchases.

By Maham Fatima Wed, June 17, 2026 at 10:38 PM GMT+3 2 min read · Yahoo Finance · June 17, 2026, 19:38 UTC

Caris Life Sciences Announces $100M Share Repurchase Program

Topics: AI TechBio capital structure share repurchase

Read the full article at Yahoo Finance

More World news

Pomerantz Law Firm Investigates Cumberland Pharmaceuticals Following Clinical Trial Results and Stock Decline PR Newswire · November 12, 2026, 15:05 UTC
Bybit Launches Fiat-to-Crypto Rewards Campaign with 80,000 USDT Weekly Prize Pool PR Newswire · November 12, 2026, 15:06 UTC
U.S. Existing Home Sales Decline More Than Expected in October Seeking Alpha · November 12, 2026, 15:03 UTC
Evolution PowerX Reports Q3 Revenue Growth and Positive GAAP EPS Seeking Alpha · November 12, 2026, 15:04 UTC
UBS Data Shows Trend-Following Funds Shift to Net Short Position on Global Equities Seeking Alpha · November 12, 2026, 15:00 UTC
Bridgemarq Real Estate Services Reports Q3 2026 Non-GAAP EPS of $0.07 and Revenue of $107.7M Seeking Alpha · November 12, 2026, 15:01 UTC
B. Riley Upgrades Anterix to Buy Following Spectrum Deal Optimism Seeking Alpha · November 12, 2026, 15:02 UTC
BK Technologies Reports Q3 2026 Revenue Growth Amid Production Disruptions Motley Fool · November 12, 2026, 14:57 UTC
Nio October Deliveries Decline Despite Strong Year-to-Date Growth Motley Fool · November 12, 2026, 15:00 UTC
Pomerantz Law Firm Investigates Iovance Biotherapeutics Following Clinical Trial Data Discrepancy PR Newswire · November 12, 2026, 15:00 UTC